From research to diagnosis to treatment, AI has the potential to improve outcomes for some treatments by 30 to 40 percent and reduce costs by up to 50 percent. Although healthcare algorithms are predicted to represent a $42.5B market by 2026, less than 35 algorithms have been approved by the FDA, and only two of those are classified as truly novel.1 Obtaining the large data sets necessary for generalizability, transparency, and reducing bias has historically been difficult and time-consuming, due in large part to regulatory restrictions enacted to protect patient data privacy. That's why the University of California, San Francisco (UCSF) collaborated with Microsoft, Fortanix, and Intel to create BeeKeeperAI. It enables secure collaboration between algorithm owners and data stewards (for example, healthy systems, etc.) in a Zero Trust environment (enabled by Azure Confidential Computing), protecting the algorithm intellectual property (IP) and the data in ways that eliminate the need to de-identify or anonymize Protected Health Information (PHI)--because the data is never visible or exposed. By uncovering powerful insights in vast amounts of information, AI and machine learning can help healthcare providers to improve care, increase efficiency, and reduce costs.

The U.S. Food and Drug Administration recently partnered with Health Canada and the UK's Medicines and Healthcare products Regulatory Agency to issue guiding principles to align efforts and standards for artificial intelligence and machine learning medical device development in health care. "The FDA believes that artificial intelligence and machine learning technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated during the delivery of health care every day," said Jim McKinney, public affairs specialist at the FDA, in an email to The Well News. McKinney said the 10 guiding principles grew out of collaborative discussions with Health Canada and MHRA, and learning from several sectors that applied AI and ML technologies for years and have developed good practices that can be readily applied to the medical device industry. Evidence from published information, expert and other public perspectives and review experience was used to develop the guiding principles that will be used by the agency to lay the foundation for the development of Good Machine Learning Practice, which will unify international efforts for medical device development. Over the past decade the FDA has reviewed and authorized a growing number of devices legally marketed with machine learning and expects this trend to continue.

While the term "healthcare consumerism" has been used since the 1930s, today the term refers to the importance of creating a more patient or consumer-centered experience. Patients want a more integrated, seamless healthcare experience that focuses on their particular needs. Artificial intelligence (A.I.), big tech, and big data give patients more transparency, more choice, and more flexibility across the healthcare ecosystem, which helps to facilitate a more positive healthcare experience. But the use of A.I. and machine learning to improve the patient experience, particularly and most importantly in treatment outcomes, begins long before the application of telemedicine, online appointment setting, digitalization, access to real-time information and price transparency, all of which are being used within the ecosystem with varying degrees of success. Where does healthcare consumerism really begin?

In this study we worked on the classification of the Chess Endgame problem using different algorithms like logistic regression, decision trees and neural networks. Our experiments indicates that the Neural Networks provides the best accuracy (85%) then the decision trees (79%). We did these experiments using Microsoft Azure Machine Learning as a case-study on using Visual Programming in classification. Our experiments demonstrates that this tool is powerful and save a lot of time, also it could be improved with more features that increase the usability and reduce the learning curve. We also developed an application for dataset visualization using a new programming language called Ring, our experiments demonstrates that this language have simple design like Python while integrates RAD tools like Visual Basic which is good for GUI development in the open-source world

"The skull acts as a bastion of privacy; the brain is the last private part of ourselves," Australian neurosurgeon Tom Oxley says from New York. Oxley is the CEO of Synchron, a neurotechnology company born in Melbourne that has successfully trialled hi-tech brain implants that allow people to send emails and texts purely by thought. In July this year, it became the first company in the world, ahead of competitors like Elon Musk's Neuralink, to gain approval from the US Food and Drug Administration (FDA) to conduct clinical trials of brain computer interfaces (BCIs) in humans in the US. Synchron has already successfully fed electrodes into paralysed patients' brains via their blood vessels. The electrodes record brain activity and feed the data wirelessly to a computer, where it is interpreted and used as a set of commands, allowing the patients to send emails and texts.

The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate. And in the bigger scenario of a massive $11-trillion-plus global healthcare industry, America is definitely not first. Americans are fed up, and a digital revolution that goes way beyond telemedicine is the only thing that will restore control. Mentioned in today's commentary includes: Sage Therapeutics, Inc. (NASDAQ: SAGE), Cassava Sciences, Inc. (NASDAQ: SAVA), COMPASS Pathways plc (NASDAQ: CMPS), Neuronetics, Inc. (NASDAQ: STIM), Acadia Healthcare Company, Inc. (NASDAQ: ACHC). Fixing it is a highly disruptive, multi-trillion-dollar opportunity.

I am regularly asked to summarize my many posts. I thought it would be a good idea to publish on this blog, every Monday, some of the most relevant articles that I have already shared with you on my social networks. Today I will share some of the most relevant articles about Artificial Intelligence and in what form you can find it in today's life. I will also comment on the articles. Artificial Intelligence is often viewed as a potential threat to humanity, but it can also be viewed as a valuable tool. From self-driving cars to automated security systems, AI is gradually becoming a valuable resource in our everyday lives.

The U.S. Food and Drug Administration released a list of "guiding principles" this week aimed at helping promote the safe and effective development of medical devices that use artificial intelligence and machine learning. The FDA, along with its U.K. and Canadian counterparts, said the principles are intended to lay the foundation for Good Machine Learning Practice. "As the AI/ML medical device field evolves, so too must GMLP best practice and consensus standards," said the agency regarding the principles. As the FDA notes, AI and ML technologies have the potential to radically expand the healthcare industry – but their complexity also presents unique considerations. The 10 guiding principles identify points at which international standards organizations and other collaborative bodies, including the International Medical Device Regulators Forum, could work to advance GMLP.

… Drug Administration (“FDA” or the “Agency”) held a virtual workshop entitled, Transparency of Artificial Intelligence (“AI”)/Machine Learning.

From research to diagnosis to treatment, AI has the potential to improve outcomes for some treatments by 30 to 40 percent and reduce costs by up to 50 percent. Although healthcare algorithms are predicted to represent a $42.5B market by 2026, less than 35 algorithms have been approved by the FDA, and only two of those are classified as truly novel.1 Obtaining the large data sets necessary for generalizability, transparency, and reducing bias has historically been difficult and time-consuming, due in large part to regulatory restrictions enacted to protect patient data privacy. That's why the University of California, San Francisco (UCSF) collaborated with Microsoft, Fortanix, and Intel to create BeeKeeperAI. It enables secure collaboration between algorithm owners and data stewards (for example, healthy systems, etc.) in a Zero Trust environment (enabled by Azure Confidential Computing), protecting the algorithm intellectual property (IP) and the data in ways that eliminate the need to de-identify or anonymize Protected Health Information (PHI)--because the data is never visible or exposed. By uncovering powerful insights in vast amounts of information, AI and machine learning can help healthcare providers to improve care, increase efficiency, and reduce costs.